Birgit Ehlken

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: August 10, 2015

REal-LIfe Evidence of stroke prevention in patients with atrial Fibrillation--The RELIEF study.

Journal: International journal of cardiology

Published: July 21, 2015

Effectiveness of Additional Risk Minimization Measures Related to Interstitial Lung Disease/Pneumonitis With Trastuzumab Deruxtecan Treatment of Breast Cancer in European Countries: Results and Learnings From a Post-Authorization Safety Survey Among Physicians.

Effectiveness of Additional Risk Minimization Measures Related to Interstitial Lung Disease/Pneumonitis With Trastuzumab Deruxtecan Treatment of Breast Cancer in European Countries: Results and Learnings From a Post-Authorization Safety Survey Among Physicians.

Effectiveness of risk minimization measures for valproate: a drug utilization study based on implementation of a risk minimization programme in Europe, analysis of data from the UK.

Effectiveness of risk minimization measures for valproate: a drug utilization study based on implementation of a risk minimization programme in Europe, analysis of data from the UK.

Effectiveness of risk minimisation measures for valproate: a drug utilisation study in Europe, analysis of data from Spain.

Effectiveness of risk minimisation measures for valproate: a drug utilisation study in Europe, analysis of data from Spain.

Authors' reply to Schaffalitzky de Muckadell and colleague's Comment on "Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017".

Authors' reply to Schaffalitzky de Muckadell and colleague's Comment on "Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017".

Drug utilization patterns of flupirtine following implementation of risk minimization measures in Germany.

Drug utilization patterns of flupirtine following implementation of risk minimization measures in Germany.

Use of azilsartan medoxomil in the primary-care setting in Germany: A real-world evidence study .

Use of azilsartan medoxomil in the primary-care setting in Germany: A real-world evidence study .

Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017.

Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017.

A drug utilization study to evaluate effectiveness of risk minimization measures for trimetazidine in France, Hungary, Romania and Spain.

A drug utilization study to evaluate effectiveness of risk minimization measures for trimetazidine in France, Hungary, Romania and Spain.

The impact of risk minimization measures on compliance and prescribing practices of flupirtine in Germany.

The impact of risk minimization measures on compliance and prescribing practices of flupirtine in Germany.

Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review.

Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review.

Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation.

Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation.

REal-LIfe Evidence of stroke prevention in patients with atrial Fibrillation--The RELIEF study.

REal-LIfe Evidence of stroke prevention in patients with atrial Fibrillation--The RELIEF study.

Use of azilsartan medoxomil in the primary-care setting in Germany: A real-world evidence study .

Use of azilsartan medoxomil in the primary-care setting in Germany: A real-world evidence study .